PubMed Health⌕ Search

Biomedical subjects

D Andreev

Publications and source records attributed to D Andreev.

At least 37 records · Page 2Linked to original sources

[Pathogenesis of diabetes in adulthood. II. The nature of the insulin secretory defect].

Insulin secretion was studied during three successive stimulations: with tolbutamid, with tolbutamid +0.25 g glucose/kg body weight and with tolbutamid +0.50 g glucose/kg body weight in 30 patients with diabetes mellitus at a mature age, subdivided into two groups (SUP-sensitive and SUP-resistant). The rate of insulin secretion was found, in the first 10 minutes (early insulin secretion) to depend only on tolbutamid, remaining constant with blood sugar level fluctuations from 90 to 254 mg%. Later, insulinemia was higher in the test with combined loading, being most manifested with the most massive glucose loading. Similar correlation was not observed in the group of SUP resistant patients with diabetes. The results provide grounds to conclude that in SUP-sensitive diabetes, the ability of B-cells to synthesize and secrete insulin is being preserved but the sensitivity of glucose receptor versus the signal glucose information was declined. At the same time, the signal sensitivity versus other stimulations of insulin secretion, tolbutamid in this case, was still preserved. In this way, one of the possible pathogenic mechanisms of diabetes development at a mature age is elucidated.

Adult↗

[Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem].

The therapeutic effect of swine insulin preparation Lente, "Pharmachim" production was studied in 50 diabetics. Its hypoglycemizing activitis compared with that of standardized insulin Lente--"Novo", extract of bovine pancreas. The Bulgarian preparation was found to be very similar to the preparation Lente-Novo in its pharma-codynamic properties and could successfully be used in the diabetes melitus treatment. Insulin Lente Pharmachim is presumed to have lower antigenicity as an extract of swine pancreas, which is actually its great advantage for the therapeutic practice.

Adult↗

[Therapeutic effect of glibenclamide contrasted with other oral antidiabetic agents].

The investigation is realized with 50 diabetics, considered suitable for oral therapy that revealed excellent or satisfactory effect from the Glybenclamide treatment (GCL), applied separately or in combination with butyl biguanide. GCL was established to give far better results than the rest oral antidabetic drugs, permitting a better metabolic syndrome compensation. GCL effect is more manifested than that of tolbutamide. The better therapeutic effect of GCL is obvious as compared with chloropropamide and butyl biguanide, but not so well manifested as with tolbutamide. The therapeutic GCL effect is better in almost all followed up ages, the most advanced incld., which is not cogent for the rest of the oral preparations. Side effects and severe hypoglycemic incidence, reported by other authors, were not observed during the investigation.

Administration, Oral↗